SCHEMBL23873192

SCHEMBL23873192

CCOC(=O)c1cnc2ccc(C(C)(C)C)nn12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 4/20 0.44
▸ KDM4E B2RXH2 3/20 0.44
▸ GLA P06280 2/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ CYP2C9 P11712 2/20 0.44
▸ CYP2C19 P33261 2/20 0.44
▸ MAPT P10636 1/20 0.44
▸ IDO1 P14902 5/20 0.42
▸ HPGD P15428 2/20 0.40
▸ CYP1A2 P05177 1/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ TGFBR1 P36897 2/20 0.40
▸ CDK5 Q00535 2/20 0.39
▸ AURKA O14965 1/20 0.39
▸ CSF1R P07333 1/20 0.39
▸ RET P07949 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19840418 0.83 GAA (0.45) GAAKDM4EGLAMEN1KMT2A
SCHEMBL17250503 0.81 NPC1 (0.46) GAAKDM4EGLAMEN1KMT2A
SCHEMBL431424 0.81 ADORA2A (0.47) GAAKDM4EGLAMEN1KMT2A
SCHEMBL23872989 0.80 GRN (0.45) KDM4ENPC1TGFBR1CDK5AURKA
SCHEMBL20132569 0.80 KDM4E (0.42) GAAKDM4EGLAMEN1KMT2A
SCHEMBL23872992 0.79 AURKA (0.52) TGFBR1CDK5AURKACSF1RRET
SCHEMBL18041927 0.79 TGFBR1 (0.44) GAAKDM4EGLAMEN1KMT2A
SCHEMBL18041622 0.78 TGFBR1 (0.43) GAAKDM4EGLAMEN1KMT2A
SCHEMBL21024065 0.77 TGFBR1 (0.44) TGFBR1CDK5AURKACSF1RRET
SCHEMBL14881496 0.77 PIM1 (0.45) GAAKDM4EGLAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210300916-A1 NITROGENOUS HETEROCYCLIC AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION THEREOF SHANGHAI YINGLI PHARMACEUTICAL CO., LTD (CN) 2021-09-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210300916-A1 NITROGENOUS HETEROCYCLIC AROMATIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND APPLICATION THEREOF NOTUM, ALKBH5, PAH GAA 1363/4885KDM4E 1301/4885GLA 4016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback